IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
US006897238B2
(12) United States Patent (io) Patent No.: US 6,897,238 B2
Anderson (45) Date of Patent: May 24,2005
Page 2
(54) TOPICAL AMINOLEVULINIC
ACID-PHOTODYNAMIC THERAPY FOR THE TREATMENT OF ACNE VULGARIS
(75) Inventor: Richard Rox Anderson, Lexington, MA (US)
(73) Assignee: General Hospital Corporation,
Boston, MA (US)
( * ) Notice: Subject to any disclaimer, the term ol this patent is extended or adjusted under 35 U.S.C. 154(b) by 15 days.
(21) Appl. No.: 09/929,384
(22) Filed: Aug. 14, 2001
(65) Prior Publication Data
US 2002/0099094 Al Jul. 25, 2002
Related U.S. Application Data
(60) Provisional application No. 60/225,691, filed on Aug. 16, 2000.
(51) Int. CI.7 A61K 31/195; A61K 7/42
(52) U.S. CI 514/563; 514/561; 514/814;
424/59
(58) Field of Search 514/561, 814,
514/563, 410; 424/59, 60
(56) References Cited
U.S. PATENT DOCUMENTS
![[blocks in formation]](http://www.google.com.au/patents?id=0AEVAAAAEBAJ&ie=ISO-8859-1&output=text&pg=PA1&img=1&zoom=3&hl=en&q=&cds=1&sig=ACfU3U1N80Wk2QdrwO4dL_JRDri-H34d2A&edge=0&edge=stretch&ci=482,191,378,49)
![[table]](http://www.google.com.au/patents?id=0AEVAAAAEBAJ&ie=ISO-8859-1&output=text&pg=PA1&img=1&zoom=3&hl=en&q=&cds=1&sig=ACfU3U1N80Wk2QdrwO4dL_JRDri-H34d2A&edge=0&edge=stretch&ci=150,732,358,497)
![[merged small][table]](http://www.google.com.au/patents?id=0AEVAAAAEBAJ&ie=ISO-8859-1&output=text&pg=PA1&img=1&zoom=3&hl=en&q=&cds=1&sig=ACfU3U1N80Wk2QdrwO4dL_JRDri-H34d2A&edge=0&edge=stretch&ci=479,235,341,250)
OTHER PUBLICATIONS
Joris Kloek and Gerard M.J. Beijersbergen van Henegouwen, Photochemistry and Photobiology, Prodrugs of 5-Aminolevulinic Acid for Photodynamic Therapy, pp. 994-1000, 64(6), (1996).
Hongcharu et al., The Society for Investigative Dermatology, Inc., Topical ALA-Photodynamic Therapy for the Treatment of Acne Vulgaris, pp. 1-9 (2000).
Peng et al., Journal of Photochemistry and Photobiology B. Biology 34, Build up of esterfield aminolevulinic-acidderivative-induced porphyrin fluorescence in normal mouse skin, pp. 95-96 (1996).
Mutzhas, et al. "A New Apparatus with High Radiation Energy Between 320^-60 nm: Physical Description and Dermatological Applications" The Journal of Investigative Dermatology, vol. 76 pp. 42-47 (1981).
Gfesser, et al., "Seasonal Variations in the Severity of Acne Vulgaris" International Journal of Dermatology, vol. 35, No. 2, pp. 116-117 (1996).
Sigurdsson et al "Phototherapy of Acne Vulgaris with Visible Light" Dermatology, vol. 194, pp. 256-260 (1997).
(Continued) Primary Examiner—-Vickie Kim
(74) Attorney, Agent, or Firm—Nutter, McClennen & Fish LLP
![[blocks in formation]](http://www.google.com.au/patents?id=0AEVAAAAEBAJ&ie=ISO-8859-1&output=text&pg=PA1&img=1&zoom=3&hl=en&q=&cds=1&sig=ACfU3U1N80Wk2QdrwO4dL_JRDri-H34d2A&edge=0&edge=stretch&ci=487,969,259,18)
Light treatments of sebaceous gland disorders with 5-aminolevulinic acid and photodynamic therapy are disclosed. A preferred treatment includes topical application of 5-aminolevulinic acid to the skin followed by light exposures with repeated treatment at various intervals. At low doses of ALA and photodynamic therapy (PDT) in single or multiple treatments, improvement in the sebaceous gland disorder, e.g., acne, provides the discovery that diminishment in sebum secretion and the eradication of bacteria occurs. At high doses of ALA and a single high energy PDT treatment, permanent changes to the sebaceous gland and sebum secretion have been discovered.
13 Claims, 15 Drawing Sheets
OTHER PUBLICATIONS
Arakane et al. "Singlet Oxygen Generation from Coproporphyrin in Propionibacterium acnes on Irradiation" Biochemical and Biophysical Research Communications, vol. 223, article 0937, pp. 578-582 (1996). Kjeldstad et al. "Changes in Polyphosphate Composition and Localization in Propionibacterium Acnes After Near-Ultraviolet Irradiation" Can J. Microbiol, vol. 37, pp. 562-567 (1991).
Naess et al. "In Vivo and in Vitro Effects of Doxycycline on Leucocyte Membrane Receptors" Clin, exp Immunol, vol. 62, pp. 310-314 (1985).
Kollias, et al. "Endogenous Skin Fluorescence Includeds Bands that may Serve as quantitative Markers of Aging and Photoaging" The Journal of Investigative Dermatology, vol. Ill, No. 5, pp. 776-780 (1998).
Brookner, et al. "Safety Analysis: Relative Risks of Ultraviolet Exposure from Fluorescence Spectroscopy and Colposcopy Are Comparable" Photochemistry and Photobiology, vol. 65, No. 6 pp. 1020-1025 (1997).
Konig, et al. "Photodynamic Induced Inactivation of Propionibacterium Acnes Using the Photosensitizer Methylene Blue and Red Light" Dermatologische Monatsschrift, vol. 178, pp. 297-300 (1992).
Dierickx, et al. "Photodynamic Therapy for Nevus Sebaceus with Topical Aminolevulinic Acid" Arch Dermatol, vol. 133, pp. 637-640 (1999).
Konig, et al. "photodynamische Akitvitat von methylenblau" Akt. Dermatol, vol. 19, pp. 195-198 (1993). Konig, et al. "Photodynamically Inactivation of Propionibacterium Acnes" SPIE, vol. 3247 pp. 106-110 (1998). Mills, et al. "Ultraviolet Phototherapy and Photochemotherapy of Acne Vulgaris" Arch Dermatol, vol. 114, pp. 221-223 (1978).
Wilkin "Pathophysiology and Treatment" Arch Dermatol, vol. 130, pp. 359-362 (1994).
Phillips, et al. "Recent Advances in Dermatology" The New England Journal of Medicine, vol. 326, No. 3, pp. 167-178 (1992).
* cited by examiner
FOLLOW-UP VISIT IWEEK) „ ■ SINGLE TREATMENT GROUP - MULTIPLE TREATMENT GROUP
« PreviousContinue » |